Caszyme featured in BioProcess International!
We’re thrilled to see Caszyme’s work highlighted in BioProcess International, showcasing our novel Cas12l nuclease and the potential of innovative CRISPR tools like this to advance the cell and gene therapy (CGT) landscape.
In the article, Giedrius Gasiunas and Monika Paule discuss Caszyme’s ongoing efforts to bring these discoveries closer to impactful treatments – building a therapeutic pipeline for retinal disorders and cancer.
Read more about Cas12l and our in-house therapeutic pipeline in the full article here.